Company / Accounts Receivable
Envista Holdings Accounts Receivable History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Accounts Receivable
$429.6M
FY2025
5-year range
$331.9M / $429.6M
FY2021-FY2025
Trend
+18.3%
vs FY2024
Sector context
#51 of 143
Health Care
What the data says
At $430M, Envista Holdings's accounts receivable ranks #51 of 143 in the Health Care sector. Accounts Receivable has fluctuated over the past 8 years, ranging from $302M in FY2020 to $460M in FY2018.
Based on SEC 10-K filings.
$430M in FY2025 with a 5-year CAGR of +7.3%.
Improved from $408M to $430M over the past 2 years.
Health Care sector context is included.
Accounts Receivable over time
Growth rates
- 3-Year CAGR
- +3.0%
- 5-Year CAGR
- +7.3%
- 10-Year CAGR
- -
Sector benchmark
#51 of 143 in Health CareTop 36% of 143This company $429.6M Sector average $1.3B
▼
-67.7% below sector average
Key checks
Key Insights
- 5-year CAGR of +7.3%, indicating consistent growth.
- In FY2025, accounts receivable increased 18.3% year-over-year.
- Ranks #51 out of 143 companies in the Health Care sector.
- Peak accounts receivable was recorded in FY2018.
Company context
Key Data Points
- Altman Z-Score 1.19 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Accounts ReceivableValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $429.6M | +18.3% |
| FY2024 | $363.0M | -10.9% |
| FY2023 | $407.5M | +3.6% |
| FY2022 | $393.5M | +18.6% |
| FY2021 | $331.9M | +10.0% |
| FY2020 | $301.7M | -32.0% |
| FY2019 | $443.6M | -3.5% |
| FY2018 | $459.8M | - |
| FY2017 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026